{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "21219844",
  "DateCompleted": {
    "Year": "2011",
    "Month": "02",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "dan"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1603-6824",
      "JournalIssue": {
        "Volume": "173",
        "Issue": "2",
        "PubDate": {
          "Year": "2011",
          "Month": "Jan",
          "Day": "10"
        }
      },
      "Title": "Ugeskrift for laeger",
      "ISOAbbreviation": "Ugeskr Laeger"
    },
    "ArticleTitle": "[Risk of affective disorder in multiple sclerosis].",
    "Pagination": {
      "StartPage": "123",
      "EndPage": "126",
      "MedlinePgn": "123-6"
    },
    "Abstract": {
      "AbstractText": [
        "An increased risk for depression has been found in multiple sclerosis (MS). The purpose of the present study has been to give suggestions to guidelines for diagnosis and treatment of depression in MS in Denmark based on the international literature and recommendations. The method was a review of the relevant literature. The study recommends assessment of all MS patients for depression. Treatment of depression with serotonin reuptake inhibitors and/or cognitive behavioural therapy is recommended, depending on the severity of the illness. Caution is recommended in patients receiving beta interferon treatment."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Psykiatrisk Afdeling, Odense Universitetshospital, Odense, Denmark. e.stenager@hotmail.com"
          }
        ],
        "LastName": "Stenager",
        "ForeName": "Elsebeth Nylev",
        "Initials": "EN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Stage",
        "ForeName": "Kurt Bjerregaard",
        "Initials": "KB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Stenager",
        "ForeName": "Egon",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "English Abstract",
      "Journal Article"
    ],
    "VernacularTitle": "Risiko for affektiv lidelse ved multipel sklerose."
  },
  "MedlineJournalInfo": {
    "Country": "Denmark",
    "MedlineTA": "Ugeskr Laeger",
    "NlmUniqueID": "0141730",
    "ISSNLinking": "0041-5782"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Immunologic Factors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Serotonin Uptake Inhibitors"
    },
    {
      "RegistryNumber": "77238-31-4",
      "NameOfSubstance": "Interferon-beta"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Bipolar Disorder"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Depressive Disorder"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Immunologic Factors"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Interferon-beta"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Multiple Sclerosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Guidelines as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Selective Serotonin Reuptake Inhibitors"
    }
  ]
}